Andrei G, Snoeck R. Advances and perspectives in the management of Varicella-Zoster virus infections. Molecules. 2021;26:1132.
Google Scholar
Arvin AM. Creating the dew drop on a Rose petal: the molecular pathogenesis of Varicella-Zoster virus skin lesions. Microbiol Mol Biol Rev. 2023;87:e0011622.
Google Scholar
World Health Organization. Varicella and herpes Zoster vaccines: WHO position paper, June 2014. Wkly Epidemiol Rec. 2014;89:265–87.
Williame I, George M, Shah HA, et al. Healthcare resource use and costs of varicella and its complications: A systematic literature review. Hum Vaccin Immunother. 2023;19:2266225.
Google Scholar
Sui H, Li J, Wang M, et al. Varicella epidemiology in china, 2005–2015. Chin J Vaccin Immuniz. 2019;25:155–9.
Dong P, Wang M, Liu Y. Epidemiological characteristics of varicella in china, 2016–2019. Chin J Vaccin Immuniz. 2020;26:403–6.
Wang M, Zeng X, Zhang Y, et al. Epidemiological characteristics of varicella public health emergency events in china, 2007–2021. Chin J Vaccin Immuniz. 2023;29:274–9.
Otani N, Shima M, Yamamoto T et al. Effect of routine varicella immunization on the epidemiology and immunogenicity of varicella and shingles. Viruses. 2022;14:588.
Lopez AS, Zhang J, Brown C, et al. Varicella-related hospitalizations in the united states, 2000–2006: the 1-dose varicella vaccination era. Pediatrics. 2011;127:238–45.
Google Scholar
Marin M, Lopez AS, Melgar M, et al. Decline in severe varicella disease during the united States varicella vaccination program: hospitalizations and deaths, 1990–2019. J Infect Dis. 2022;226:S407–15.
Google Scholar
Huang L, Chen Z, Song Y, et al. Immunogenicity and safety of a live-attenuated varicella vaccine in a healthy population aged 13 years and older: A randomized, double-blind, controlled study. Vaccine. 2024;42:396–401.
Google Scholar
Liu A, Sun T. Meta-analysis of varicella vaccine coverage among Chinese children. Chin J Vaccin Immuniz. 2017;23:698–704.
Gil-Prieto R, Garcia-Garcia L, San-Martin M, et al. Varicella vaccination coverage inverse correlation with varicella hospitalizations in Spain. Vaccine. 2014;32:7043–6.
Google Scholar
Siedler A, Dettmann M. Hospitalization with varicella and shingles before and after introduction of childhood varicella vaccination in Germany. Hum Vaccin Immunother. 2014;10:3594–600.
Google Scholar
Hu Y, Luo X, Lv M, et al. A Meta-analysis on varicella-zoster virus antibody levels in healthy population in China. Chin J Epidemiol. 2021;42:1650–61.
Google Scholar
Marin M, Marti M, Kambhampati A, et al. Global varicella vaccine effectiveness: A Meta-analysis. Pediatrics. 2016;137:e20153741.
Google Scholar
Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.
Google Scholar
Liu Q, Zhai W, Tan YQ, et al. Analysis on evaluation tool for literature quality in clinical study. Chin Acupunct Mox. 2014;3:919–22.
Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1–12.
Google Scholar
Wells G, Shea B, O’Connell D et al. The Newcastle Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2016. Available from: http://www.ohri.ca/programs/clinicalepidemiology/oxford.asp
Piché-Renaud PP, Yue Lee E, Ji C, et al. Safety and immunogenicity of the live-attenuated varicella vaccine in pediatric solid organ transplant recipients: A systematic review and meta-analysis. Am J Transpl. 2023;23:1757–70.
Egger M, Smith GD, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.
Google Scholar
Balshem H, Helfand M, Schünemann HJ, et al. GRADE guidelines. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64:401–6.
Google Scholar
Bai Y, Yang L, Guo L, et al. Safety and immunogenicity of Gelatin-free Freeze-dried live attenuated varicella vaccine. Chin J Biol. 2011;24:1336–8.
Bian G, Tang X, Shi H, et al. Study on safety and immunogenicity of imported and domestic varicella attenuated live vaccine (Freeze-dried) for children. Chin J Vaccin Immuniz. 2012;18:435–768.
Cai Z. Observation on reaction and immune effect of lyophilized live attenuated varicella vaccine. Med Inf. 2012;25:279–80.
Google Scholar
Chen E, Jiang Z, Li Q, et al. Safety and immunogenicity of lyophilized live attenuated domestic varicella vaccine. Chin J Vaccin Immuniz. 2009;15:435–7.
Google Scholar
Dai W, Pang H, Jiang Y, et al. Study on immune effects of the second dose of varicella vaccine. Sh J Prev Med. 2017;29:194–6.
Gao Z, Wu Z, Ye X, et al. Evaluation of safety and immune efficacy of domestic lyophilized live attenuated varicella vaccine in childrenaged 1–12 years. Inter J Epidemiol Infect Dis. 2021;48:296–301.
Hu H. Evaluation of safety and immunogenicity of lyophilized live attenuated varicella vaccine. Med Inf. 2015;28:311.
Huang T, Si G, Li C, et al. Safety and immunogenicity of domestic and imported freeze-dried live attenuated varicella vaccine inoculated by a two-dose schedule in healthy population at ages of more than 12 years in China. Chin J Biol. 2016;29:610–5.
Huang Z, Zhang J, Tang Y, et al. Immunogenicity and safety of 2 doses of live attenuated varicella vaccine in children under 3 years of age. South China J Prev Med. 2018;44:265–8.
Jiang F, Zhang R, Guan Q, et al. Immunogenicity and safety of a live attenuated varicella vaccine in children 1–12 years of age: A randomized, blinded, controlled, non-inferiority phase 3 clinical trial. Contemp Clin Trials. 2021;107:106489.
Google Scholar
Jiang Z, Chen E, Li Q, et al. Observation on side effect of the domestic lyophilized live attenuated varicella vaccine. Zh Prev Med. 2009;21:12–3.
Google Scholar
Li Y, Fang H, Nong Y, et al. Study on safety and immunogenicity of domestic freeze-dried live attenuated varicella vaccine. Appl Prev Med. 2008;14:371–3.
Li Y, Gao Z, Tao H, et al. Safety of freeze-dried live attenuated varicella vaccine. Chin J Biol. 2012;25:1667–70.
Li Y. Immunogenicity analysis of domestic varicella vaccine after booster immunization. China Prac Med. 2019;14:41–3.
Liu X, Yang H, Li H, et al. Immunogenicity and safety of two doses of domestic varicella attenuated live vaccine among ≥ 13-year-old healthy population in a non-inferiority trial. Chin J Vaccin Immuniz. 2019;25:63–7.
Lu M, Liu Z, Li Y, et al. Evaluation on safety and immunogenicity of live attenuated varicella vaccine. Med Innov Chin. 2010;7:9–11.
Lu X, Zhou W, Gu K, et al. Safety and immunogenicity of Changsheng technology freeze-dried live attenuated varicella vaccine. J Southeast Univ (Medical Sci Edition). 2008;27:207–11.
Google Scholar
Luo L, Liu X, Ma Y, et al. Safety and immunogenicity of freeze-dried live attenuated varicella vaccine. Chin J Biol. 2016;29:1298–300.
Luo S, Jiang D, Huang Y, et al. Immunogenicity and safety of two-dose and booster immunization schedules of domestic varicella vaccine. Chin J Biol. 2019;32:1381–5.
Ma R, Xu G, Pan X, et al. Observation on immunogenicity of domestic freeze-dried live attenuated varicella vaccine and immunity persistence one year after vaccination. Dis Surveill. 2012;27:601–3.
Mo ZJ, Huang SJ, Qiu LX, et al. Safety and immunogenicity of a skin- and neuro-attenuated live vaccine for varicella: a randomized, double-blind, controlled, dose-escalation and age de-escalation phase 1 clinical trial. Lancet Reg Health West Pac. 2023;34:100707.
Google Scholar
Peng S, Liao Z, Wan X, et al. Safety of Chinese freeze – dried varicella attenuated live vaccine. J Med Pest Control. 2018;34:428–31.
Shen Y, Jiang X, Gu X, et al. Inoculation reaction and immune effect of domestic freeze-dried live attenuated varicella vaccine. Chin J Biol. 2003;16:314–5.
Shen Y, Lu J, Chen H. Observation on the level of varicella immunity in children in kindergarten and the effect of domestic varicella vaccine. Chin J Public Health Manage. 2007;23:72–3.
Sun H, Yuan J, Liu X. Immunogenicity and cost-effectiveness analysis of domestic varicella vaccine. Sh J Prev Med. 2003;15:445–7.
Sun H, Fang H, Li R, et al. Adverse reaction and immunogenicity induced by Freeze-dried live attenuated varicella vaccine. Chin J Biol. 2009;22:702–4.
Tang Y, Su J, Xia Y, et al. Safety and immunogenicity of domestic gelatin-free freeze-dried live attenuated varicella vaccine. Chin J Biol. 2012;25:1516–9.
Google Scholar
Tang Y, Du F, Chen H, et al. Post-Marketing immunogenicity and safety of two different live attemuatal varicella vaccine. Chin J Vaccin Immuniz. 2014;20:241–4.
Wang F, Chen Z, Chen X. Observation on efficacy of live attenuated varicella vaccine in Weifang City. Med Anim Control. 2006;22:813–4.
Google Scholar
Wang L, Liu Y, Li L, et al. Observation on immune effect of domestic freeze-dried live attenuated varicella vaccine. South China J Prev Med. 2003;29:30–1.
Wang Q, Li Y, Wang L. Safety and immunogenicity of lyophilized live attenuated varicella vaccine in children aged 1–6 years. Prev Med. 2017;29:711–3.
Wang Z, Xiao Q, Li F, et al. Safety and immunological effect of domestic varicella attenuated live vaccine (Freeze-dried). Chin J Vaccin Immuniz. 2011;17:531–4.
Zhang Q, Fei J, Zhong P, et al. Study on safety and immunogenicity of domestic freeze-dried live attenuated varicella vaccine with 2 doses. Sh Prev Med. 2017;29:59–61.
Shinefield HR, Black SB, Staehle BO, et al. Vaccination with measles, mumps and Rubella vaccine and varicella vaccine: safety, tolerability, immunogenicity, persistence of antibody and duration of protection against varicella in healthy children. Pediatr Infect Dis J. 2002;21:555–61.
Google Scholar
National Advisory Committee on Immunization (NACI). Varicella (chicken pox) vaccine: Canadian Immunization Guide [internet]. https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-4-active-vaccines/page-24-varicella-chickenpox-vaccine.html
Shi X. Comparative study on immune effect of domestic and imported varicella vaccine. Electron J Clin Med Literature. 2019;6:176.
Carta V, Mangeri L, Tiecco G, et al. Immunogenicity and safety of live attenuated and recombinant/inactivated varicella Zoster vaccines in people living with HIV: A systematic review. Hum Vaccin Immunother. 2024;20:2341456.
Google Scholar
Yin M, Xu X, Liang Y, et al. Effectiveness, immunogenicity and safety of one vs. two-dose varicella vaccination: a meta-analysis. Expert Rev Vaccines. 2018;17:351–62.
Google Scholar
Su JR, Leroy Z, Lewis PW et al. Safety of Second-Dose Single-Antigen varicella vaccine. Pediatrics. 2017;139:e20162536.
Kuter BJ, Brown M, Wiedmann RT, et al. Safety and immunogenicity of M-M-RII (Combination Measles-Mumps-Rubella Vaccine) in clinical trials of healthy children conducted between 1988 and 2009. Pediatr Infect Dis J. 2016;35:1011–20.
Google Scholar